Prospect Capital Backs Latest Buckingham Acquisition

Prospect Capital Corporation has provided $31.1 million of senior secured debt to VanDeMark Chemical, a specialty chemical manufacturer and a portfolio company of Buckingham Capital Partners. “Prospect’s responsiveness enabled an on-time execution of a complex refinancing that we desired to close before year end,” said Albert Naggar, a Managing Partner of Buckingham. “We look forward to working with Prospect in the future.”

VanDeMark manufactures phosgene and phosgene derivatives to serve the global pharmaceutical, agricultural-chemical, polymer, and fine chemical industries. The company is based in Lockport, NY (

“We are delighted to support Buckingham in its recapitalization of VanDeMark,” said Bart de Bie, a Managing Director with Prospect Capital Management. “Prospect has significant domain expertise in the specialty chemicals industry in addition to other industry verticals.”

Prospect invests from $10 million to $75 million in private and micro-cap public businesses located in the US and Canada that have from $3 million to $30 million of EBITDA. Investment structures include: senior debt; unitranche debt; 2nd lien and mezzanine debt; and “one stop” debt and equity. The firm invests in wide array of industries and is effectively industry agnostic. Prospect Capital is located in New York, NY (

Buckingham Capital Partners makes control equity investments of $2 million to $15 million in leveraged and management buyouts and recapitalizations of industrial and manufacturing companies in the $10 million to $100 million valuation range. The firm is based in New York, NY (